{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:10:05Z","timestamp":1752228605945,"version":"3.41.2"},"reference-count":22,"publisher":"Jaypee Brothers Medical Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.59556\/japi.72.0671","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:42:57Z","timestamp":1752226977000},"page":"16-18","source":"Crossref","is-referenced-by-count":0,"title":["Unique Pharmacological Properties and Safety Profiles of Loop Diuretics"],"prefix":"10.59556","volume":"72","author":[{"given":"Mohan","family":"Lal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasant Kumar","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan","family":"Nisty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharukh","family":"Golwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvro","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopinath","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idris Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Zalte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilnathan","family":"Mohanasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"key":"key20250711094252_B1","article-title":"Loop diuretics.","volume-title":"StatPearls [Internet].","author":"Huxel","year":"2023."},{"key":"key20250711094252_B2","doi-asserted-by":"crossref","first-page":"112855.","DOI":"10.1016\/j.ejmech.2020.112855","article-title":"Modern trends in diuretics development.","volume":"208:","author":"Titko","year":"2020;","journal-title":"Eur J Med Chem"},{"issue":"(2):","key":"key20250711094252_B3","doi-asserted-by":"crossref","first-page":"198\u2013","DOI":"10.1038\/ki.1987.192","article-title":"Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients.","volume":"32","author":"Inoue","year":"1987;","journal-title":"Kidney Int"},{"issue":"(8):","key":"key20250711094252_B4","doi-asserted-by":"crossref","first-page":"1248\u2013","DOI":"10.2215\/CJN.09630818","article-title":"Clinical pharmacology in diuretic use.","volume":"14","author":"Ellison","year":"2019;","journal-title":"Clin J Am Soc Nephrol"},{"issue":"(5):","key":"key20250711094252_B5","doi-asserted-by":"crossref","first-page":"287\u2013","DOI":"10.1111\/j.1527-5299.2003.02399.x","article-title":"Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.","volume":"9","author":"Sica","year":"2003;","journal-title":"Congest Heart Fail"},{"issue":"(1):","key":"key20250711094252_B6","doi-asserted-by":"crossref","first-page":"17\u2013","DOI":"10.5049\/EBP.2015.13.1.17","article-title":"Loop diuretics in clinical practice.","volume":"13","author":"Oh","year":"2015;","journal-title":"Electrolyte Blood Press"},{"issue":"(6):","key":"key20250711094252_B7","doi-asserted-by":"crossref","first-page":"483\u2013","DOI":"10.1016\/j.semnephrol.2011.09.003","article-title":"Update in diuretic therapy: clinical pharmacology.","volume":"31","author":"Brater","year":"2011;","journal-title":"Semin Nephrol"},{"issue":"(1):","key":"key20250711094252_B8","doi-asserted-by":"crossref","first-page":"74\u2013","DOI":"10.1097\/MJT.0b013e31818d3f67","article-title":"Diuretics: an update on the pharmacology and clinical uses.","volume":"16","author":"Reddy","year":"2009;","journal-title":"Am J Ther"},{"issue":"(5):","key":"key20250711094252_B9","doi-asserted-by":"crossref","first-page":"429\u2013","DOI":"10.2165\/00019053-200017050-00002","article-title":"Healthcare costs of patients with heart failure treated with torasemide or furosemide.","volume":"17","author":"Stroupe","year":"2000;","journal-title":"Pharmacoeconomics"},{"issue":"(7):","key":"key20250711094252_B10","doi-asserted-by":"crossref","first-page":"513\u2013","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.","volume":"111","author":"Murray","year":"2001;","journal-title":"Am J Med"},{"issue":"(2):","key":"key20250711094252_B11","doi-asserted-by":"crossref","first-page":"264\u2013","DOI":"10.1053\/j.ajkd.2021.09.029","article-title":"Diuretics in states of volume overload: core curriculum 2022.","volume":"80","author":"Novak","year":"2022;","journal-title":"Am J Kidney Dis"},{"issue":"(1):","key":"key20250711094252_B12","doi-asserted-by":"crossref","first-page":"31\u2013","DOI":"10.1038\/clpt.1994.98","article-title":"The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.","volume":"56","author":"Gehr","year":"1994;","journal-title":"Clin Pharmacol Ther"},{"issue":"(1):","key":"key20250711094252_B13","doi-asserted-by":"crossref","first-page":"90\u2013","DOI":"10.1038\/clpt.1993.116","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis.","volume":"54","author":"Schwartz","year":"1993;","journal-title":"Clin Pharmacol Ther"},{"issue":"(Suppl 3):","key":"key20250711094252_B14","doi-asserted-by":"crossref","first-page":"14\u2013","DOI":"10.2165\/00003495-199100413-00004","article-title":"Clinical pharmacology of loop diuretics.","volume":"41","author":"Brater","year":"1991;","journal-title":"Drugs"},{"issue":"(2):","key":"key20250711094252_B15","doi-asserted-by":"crossref","first-page":"345\u2013","DOI":"10.1681\/ASN.V72345","article-title":"Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid.","volume":"7","author":"Pichette","year":"1996;","journal-title":"J Am Soc Nephrol"},{"issue":"(Suppl G):","key":"key20250711094252_B16","doi-asserted-by":"crossref","first-page":"10\u2013","DOI":"10.1093\/eurheartj\/13.suppl_G.10","article-title":"Clinical pharmacology of loop diuretics in health and disease.","volume":"13","author":"Brater","year":"1992;","journal-title":"Eur Heart J"},{"issue":"(2):","key":"key20250711094252_B17","doi-asserted-by":"crossref","first-page":"182\u2013","DOI":"10.1038\/clpt.1980.148","article-title":"Furosemide in patients with heart failure: shift in dose-response curves.","volume":"28","author":"Brater","year":"1980;","journal-title":"Clin Pharmacol Ther"},{"issue":"(4):","key":"key20250711094252_B18","doi-asserted-by":"crossref","first-page":"771.","DOI":"10.3390\/pharmaceutics14040771","article-title":"Population Pharmacokinetic (Pop-PK) analysis of torsemide in healthy korean males considering CYP2C9 and OATP1B1 genetic polymorphisms.","volume":"14","author":"Jeong","year":"2022;","journal-title":"Pharmaceutics"},{"issue":"(12):","key":"key20250711094252_B19","doi-asserted-by":"crossref","first-page":"2720.","DOI":"10.3390\/pharmaceutics14122720","article-title":"Torsemide pharmacometrics in healthy adult populations including CYP2C9 genetic polymorphisms and various patient groups through physiologically based pharmacokinetic-pharmacodynamic modeling.","volume":"14","author":"Jeong","year":"2022;","journal-title":"Pharmaceutics"},{"issue":"(4):","key":"key20250711094252_B20","doi-asserted-by":"crossref","first-page":"507\u2013","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study.","volume":"4","author":"Cos\u00edn","year":"2002;","journal-title":"Eur J Heart Fail"},{"issue":"(5):","key":"key20250711094252_B21","doi-asserted-by":"crossref","first-page":"707\u2013","DOI":"10.2217\/fca.12.54","article-title":"Should torsemide be the loop diuretic of choice in systolic heart failure?","volume":"8","author":"DiNicolantonio","year":"2012;","journal-title":"Future Cardiol"},{"issue":"(3):","key":"key20250711094252_B22","doi-asserted-by":"crossref","first-page":"309\u2013","DOI":"10.1080\/003655201750074672","article-title":"Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites.","volume":"36","author":"Abecasis","year":"2001;","journal-title":"Scand J Gastroenterol"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:42:59Z","timestamp":1752226979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-9-s1-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.59556\/japi.72.0671"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0671","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}